Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Other ingredients Microcrystalline cellulose, rice extract blend, silicon dioxide, modified cellulose, croscarmellose sodium, gum fiber blend, aqueous coating
A member of the audience, Chris Bladin, MBBS, FRACP, clinical telestroke lead at the Australian Stroke Alliance, highlighted the TEXAIS randomized controlled trial on exenatide that he was principal investigator on
Front-loading protein at the first meal helps counter morning anorexia on these drugs
Bulk Drug Substances Used in Compounding Under Section 503B of the FD&C Act
Absolute contraindications: Known allergy to either peptide or its components Active cancer (insufficient safety data) Pregnancy or breastfeeding (insufficient safety data) Severe immunocompromise (theoretical concern) Relative contraindications (require careful consideration): History of cancer (consult a medical advisor) Major cardiac disease (monitor closely) Severe liver or kidney disease (may affect clearance) Active infections (wait until resolved) Bleeding disorders (monitor injection sites carefully) Special populations: Elderly subjects: usually well tolerated, no dose adjustment needed Subjects with multiple conditions: enhanced monitoring recommended Those on multiple medications: review for possible interactions Drug Interactions The peptides have minimal documented drug interactions
Trends Mol Med 7(12):542547 Altieri DC (2003) Validating survivin as a cancer therapeutic target
US$ 25.15
US$ 24.09
US$ 20.92
US$ 21.84
